The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis
Open accessAbstract
Background and aims: Study of health related quality of life (HRQOL) and the factors responsible for its impairment in primary biliary cirrhosis (PBC) has, to date, been limited. There is increasing need for a HRQOL questionnaire which is specific to PBC. The aim of this study was to develop, validate, and evaluate a patient based PBC specific HRQOL measure. Subjects and methods: A pool of potential questions was derived from thematic analysis of indepth interviews carried out with 30 PBC patients selected to represent demographically the PBC patient population as a whole. This pool was systematically reduced, pretested, and cross validated with other HRQOL measures in national surveys involving a total of 900 PBC patients, to produce a quality of life profile measure, the PBC-40, consisting of 40 questions distributed across six domains. The PBC-40 was then evaluated in a blinded comparison with other HRQOL measures in a further cohort of 40 PBC patients. Results: The six domains of PBC-40 relate to fatigue, emotional, social, and cognitive function, general symptoms, and itch. The highest mean domain score was seen for fatigue and the lowest for itch. The measure has been fully validated for use in PBC and shown to be scientifically sound. PBC patient satisfaction, measured in terms of the extent to which a questionnaire addresses the problems that they experience, was significantly higher for the PBC-40 than for other HRQOL measures. Conclusion: The PBC-40 is a short easy to complete measure which is acceptable to PBC patients and has significantly greater relevance to their problems than other frequently used HRQOL measures. Its scientific soundness, shown in extensive testing, makes it a valuable instrument for future use in clinical and research settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coefficient Alpha and the Internal Structure of Tests
Cronbach, L. J. (1951) · Psychometrika · doi:10.1007/bf02310555 · Cited by 43,931
(1992) · PubMed · Cited by 33,716
(1932) · Medical Entomology and Zoology · Cited by 9,568
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Health Measurement Scales: A practical guide to their development and use
Streiner, D. L., Norman, G. R., & Cairney, J. (2014) · doi:10.1093/med/9780199685219.001.0001 · Cited by 2,564
Assessing health status and quality-of-life instruments: Attributes and review criteria
Lohr, K. N. (2002) · Quality of Life Research · doi:10.1023/a:1015291021312 · Cited by 2,269
Quality of life and pharmacoeconomics in clinical trials
Spilker, B. (1996) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,862
Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life
Patrick, D. L., & Deyo, R. A. (1989) · Medical Care · doi:10.1097/00005650-198903001-00018 · Cited by 1,790
Qualitative research methods in health technology assessment: a review of the literature.
Murphy, Dingwall, Greatbatch, Parker, & Watson (1998) · Health Technology Assessment · doi:10.3310/hta2160 · Cited by 1,107 · cited 1×
“approaches for qualitative research [ 21 ] the 30 participants were selected for initial in-depth”
Method
Research works printed but not linked: 16
- 10.1111/j.1572-0241.2000.01774.x · doi:10.1111/j.1572-0241.2000.01774.x · Paper page
- 2000, Am J Gastroenterol, 95, 3552, 10.1111/j.1572-0241.2000.03375.x · doi:10.1111/j.1572-0241.2000.03375.x · Paper page
- 1994, Adv Med Sociol, 5, 255
- 10.1177/026921559901300306 · doi:10.1177/026921559901300306
- 1998, Health Technol Assess, 2, 16
- 1932, Arch Psychol, 140, 1
- 1999, Med Care, 37, MS10
- 10.1097/00005650-199206000-00002 · DOI · Paper page
- Jenkinson C, Layte R, Wright L, et al. The UK SF-36: An analysis and interpretation manual. Oxford: University of Oxford, 1996.
- 1993, Epilepsia, 34, S22
- 1954, Psychometrika, 16, 297
- Nunnally J, Bernstein JC. Psychometric theory, 3rd Edn. New York: McGraw-Hill 1994.
- Streiner DL, Norman GR. Health Measurement Scales. 2nd Edn, Oxford: Oxford University Press, 1995.
- 2001, QOL Research, 10, 579
- 2001, Qual Life Newsletter, 6, 2
- 2000, J Neurolinguistics, 13, 267
Cited by
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationA Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509840 · Cited by 1,131
Self-citationCarbone, M., Mells, G. F., Pells, G., Dawwas, M. F., Newton, J. L., Heneghan, M. A., Neuberger, J. M., Day, D. B., Ducker, S. J., Sandford, R. N., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.12.005 · Cited by 386
Self-citationHirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Self-citationEfficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Kowdley, K. V., Bowlus, C. L., Levy, C., Akarca, U. S., Alvares-da-Silva, M. R., Andreone, P., Arrese, M., Corpechot, C., Francque, S. M., Heneghan, M. A., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2306185 · Cited by 314
Self-citationnorUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H.-U., Altorjay, I., Färkkilä, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.009 · Cited by 297
Peng, J.-K., Hepgul, N., Higginson, I. J., & Gao, W. (2019) · Palliative Medicine · doi:10.1177/0269216318807051 · Cited by 283
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
Hirschfield, G. M., Bowlus, C. L., Mayo, M. J., Kremer, A. E., Vierling, J. M., Kowdley, K. V., Levy, C., Villamil, A., Ladrón de Guevara Cetina, A. L., Janczewska, E., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2312100 · Cited by 286
Primary biliary cirrhosis: A 2010 update
Poupon, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.027 · Cited by 274
Hirschfield, G. M., & Heathcote, E. J. (2010) · Evidence‐Based Gastroenterology and Hepatology · doi:10.1002/9781444314403.ch32 · Cited by 261
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study
Mells, G. F., Pells, G., Newton, J. L., Bathgate, A. J., Burroughs, A. K., Heneghan, M. A., Neuberger, J. M., Day, D. B., Ducker, S. J., Sandford, R. N., et al. (2013) · Hepatology · doi:10.1002/hep.26365 · Cited by 227
Self-citationSchattenberg, J. M., Pares, A., Kowdley, K. V., Heneghan, M. A., Caldwell, S., Pratt, D., Bonder, A., Hirschfield, G. M., Levy, C., Vierling, J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.013 · Cited by 191
Self-citationTanaka, A., Ma, X., Takahashi, A., & Vierling, J. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01303-5 · Cited by 177
Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology†
Newton, J. L., Hollingsworth, K. G., Taylor, R., El‐Sharkawy, A. M., Khan, Z. U., Pearce, R., Sutcliffe, K., Okonkwo, O., Davidson, A., Burt, J., et al. (2008) · Hepatology · doi:10.1002/hep.22371 · Cited by 156
Self-citationFour year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort
Jones, D. E. J., Bhala, N., Burt, J., Goldblatt, J., Prince, M., & Newton, J. L. (2006) · Gut · doi:10.1136/gut.2005.080317 · Cited by 136
Self-citationYou, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10276-6 · Cited by 133
Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis
Schramm, C., Wahl, I., Weiler-Normann, C., Voigt, K., Wiegard, C., Glaubke, C., Brähler, E., Löwe, B., Lohse, A. W., & Rose, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.035 · Cited by 128
Hirschfield, G. M., Shiffman, M. L., Gulamhusein, A., Kowdley, K. V., Vierling, J. M., Levy, C., Kremer, A. E., Zigmond, E., Andreone, P., Gordon, S. C., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000395 · Cited by 127
Self-citationMayo, M. J., Wigg, A. J., Leggett, B. A., Arnold, H., Thompson, A. J., Weltman, M., Carey, E. J., Muir, A. J., Ling, L., Rossi, S. J., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1209 · Cited by 125
The challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114
Self-citationCarbone, M., Bufton, S., Monaco, A., Griffiths, L., Jones, D. E., & Neuberger, J. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.017 · Cited by 115
Self-citationJONES, D. E. J., & NEWTON, J. L. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03223.x · Cited by 114
“The psychometric properties of the PBC-40 have been previously been described in detail (18).”
BackgroundMethodSelf-citationLevy, C., Kendrick, S., Bowlus, C. L., Tanaka, A., Jones, D., Kremer, A. E., Mayo, M. J., Haque, N., von Maltzahn, R., Allinder, M., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.10.032 · Cited by 101
Self-citationJones, D. E., Al-Rifai, A., Frith, J., Patanwala, I., & Newton, J. L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.026 · Cited by 91
“Given that fatigue assessment is easy to carry out in the clinical setting (the validated tools such as the FIS and PBC-40 are designed for self-completion, are acceptable to patients and take less than 5 min to complete [15,17,18] and essentially cost-free) it is logical that it be incorporated into normal clinic fol…”
Self-citationHollingsworth, K. G., Newton, J. L., Taylor, R., McDonald, C., Palmer, J. M., Blamire, A. M., & Jones, D. E. J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.013 · Cited by 89
Self-citationWang, L., Han, Q., Chen, H., Wang, K., Shan, G.-L., Kong, F., Yang, Y.-J., Li, Y.-Z., Zhang, X., Dong, F., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0500 · Cited by 89
Silveira, M. G., Brunt, E. M., Heathcote, J., Gores, G. J., Lindor, K. D., & Mayo, M. J. (2010) · Hepatology · doi:10.1002/hep.23637 · Cited by 87
Invernizzi, P., Carbone, M., Jones, D., Levy, C., Little, N., Wiesel, P., Nevens, F., & the study investigators (2023) · Liver International · doi:10.1111/liv.15596 · Cited by 79
Self-citationDyson, J. K., Wilkinson, N., Jopson, L., Mells, G., Bathgate, A., Heneghan, M. A., Neuberger, J., Hirschfield, G. M., Ducker, S. J., The UK‐PBC Consortium, et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13794 · Cited by 78
Self-citationKhanna, A., Jopson, L., Howel, D., Bryant, A., Blamire, A., Newton, J. L., & Jones, D. E. (2019) · Hepatology · doi:10.1002/hep.30099 · Cited by 75
“Other symptom severity assessed by the relevant domains of the PBC-40 (itch, cognition, social, emotional, and symptoms).(22) Anxiety and depression were assessed by the Hospital Anxiety and Depression Scale (HADS) score (range 0-42)(23); daytime somnolence by the Epworth Sleeping Scale (ESS) (range 0-24)(24); vasomot…”
BackgroundMethodSelf-citationCheung, A. C., Patel, H., Meza-Cardona, J., Cino, M., Sockalingam, S., & Hirschfield, G. M. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-4013-1 · Cited by 68
The role of psychological factors in the fatigue of primary biliary cirrhosis
Blackburn, P., Freeston, M., Baker, C. R., Jones, D. E. J., & Newton, J. L. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01500.x · Cited by 67
Self-citationSilveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H., & Lindor, K. D. (2017) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000387 · Cited by 64
An integrated care pathway improves quality of life in Primary Biliary Cirrhosis
Jones, D. E. J., Sutcliffe, K., Pairman, J., Wilton, K., & Newton, J. L. (2008) · QJM · doi:10.1093/qjmed/hcn043 · Cited by 58
Self-citationPusl, T., Denk, G. U., Parhofer, K. G., & Beuers, U. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.008 · Cited by 50
Younossi, Z. M., Afendy, A., Stepanova, M., Racila, A., Nader, F., Gomel, R., Safer, R., Lenderking, W. R., Skalicky, A., Kleinman, L., et al. (2018) · Hepatology · doi:10.1002/hep.29664 · Cited by 48
Assessment of health related quality of life in polish patients with primary biliary cirrhosis
Raszeja-Wyszomirska, J., Wunsch, E., Krawczyk, M., Rigopoulou, E. I., Kostrzewa, K., Norman, G. L., Bogdanos, D. P., & Milkiewicz, P. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.10.006 · Cited by 47
Wunsch, E., Norman, G. L., Milkiewicz, M., Krawczyk, M., Bentow, C., Shums, Z., Mahler, M., Lopens, S., Reinhold, D., Franke, A., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16153 · Cited by 43
Raszeja‐Wyszomirska, J., Wunsch, E., Krawczyk, M., Rigopoulou, E. I., Bogdanos, D., & Milkiewicz, P. (2015) · Liver International · doi:10.1111/liv.12730 · Cited by 43
Jones, D., Carbone, M., Invernizzi, P., Little, N., Nevens, F., Swain, M. G., Wiesel, P., & Levy, C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000057 · Cited by 37
Self-citationRice, S., Albani, V., Minos, D., Fattakhova, G., Mells, G. F., Carbone, M., Flack, S., Varvaropoulou, N., Badrock, J., Spicer, A., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.025 · Cited by 32
Self-citationKim, H. P., Lieber, S. R., Rogers, M. E., Moon, A. M., Loiselle, M., Walker, J., Assis, D. N., Safer, R., Gomel, R., & Evon, D. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1567 · Cited by 27
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison
Montali, L., Gragnano, A., Miglioretti, M., Frigerio, A., Vecchio, L., Gerussi, A., Cristoferi, L., Ronca, V., D’Amato, D., O’Donnell, S. E., et al. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100081 · Cited by 26
Self-citationPrimary biliary cirrhosis is associated with falls and significant fall related injury
Frith, J., Kerr, S., Robinson, L., Elliott, C., Ghazala, C., Wilton, K., Pairman, J., Jones, D. E. J., & Newton, J. L. (2010) · QJM · doi:10.1093/qjmed/hcp188 · Cited by 21
Self-citationDunn, S., Evans, L., Kennedy, C., Wafer, R., Moody, S., Wolstenhulme, F., Burton, E., Konkoth, A. B., Fisher, H., Chadwick, T., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113812
Self-citation
Metadata
- Authors
- Jacoby, A., Rannard, A., Buck, D., Bhala, N., Newton, J. L., James, O. F. W., & Jones, D. E. J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-06-16
- Volume
- 54
- Issue
- 11
- Pages
- 1622-1629
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2134836501
- Cited by
- 267
- References
- 44
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.